Berman Capital Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$392K Sell
1,850
-165
-8% -$38K 0.06% 162
2021
Q2
$491K Buy
2,015
+318
+19% +$78.2K 0.08% 120
2021
Q1
$421K Buy
1,697
+410
+32% +$97.8K 0.09% 111
2020
Q4
$295K Buy
1,287
+90
+8% +$20.8K 0.07% 124
2020
Q3
$304K Sell
1,197
-234
-16% -$58K 0.09% 103
2020
Q2
$336K Buy
1,431
+378
+36% +$86.2K 0.09% 90
2020
Q1
$213K Buy
1,053
+354
+51% +$77.3K 0.07% 113
2019
Q4
$168K Buy
699
+17
+2% +$3.75K 0.05% 155
2019
Q3
$132K Buy
682
+152
+29% +$29.2K 0.04% 178
2019
Q2
$97K Sell
530
-95
-15% -$17K 0.03% 209
2019
Q1
$117K Buy
625
+194
+45% +$37K 0.04% 174
2018
Q4
$83K Buy
+431
New +$84.1K 0.03% 195

Other funds holding AMGN

Berman Capital Advisors's AMGN Position: Q3 2021 in Review

Berman Capital Advisors reduced its Amgen (AMGN) stake by 8.2% in Q3 2021, selling an estimated $38K and leaving 1,850 shares worth $392K. The position accounts for 0.06% of the portfolio, ranked #162.

Berman Capital Advisors first reported a position in AMGN in Q4 2018 and has held it in 12 quarters since. The position peaked at $491K in Q2 2021. 2,132 funds tracked by Wall St. Rank hold AMGN as of Q3 2021.

  • Berman Capital Advisors held 1,850 shares of Amgen worth $392K as of Q3 2021.
  • Berman Capital Advisors sold 165 Amgen shares in Q3 2021, an estimated $38K.
  • Amgen made up 0.06% of Berman Capital Advisors's portfolio in Q3 2021, its #162 holding.
  • Berman Capital Advisors first reported a position in Amgen in Q4 2018 and has held it in 12 quarters since.
  • Berman Capital Advisors's Amgen position peaked at $491K in Q2 2021.
  • 2,132 funds tracked by Wall St. Rank held Amgen as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.